Related Experiment Video
Updated: Aug 8, 2026
Antibody Profiling by Luciferase Immunoprecipitation Systems (LIPS)
Published on: October 8, 2009
[Monitoring of the treatment effectiveness in patients with leprosy using solid-phase immunoenzyme assay]
Insights
This study shows that a specific antibody test can effectively monitor leprosy treatment. Antibody levels decrease with successful therapy, indicating treatment effectiveness in multibacillary leprosy patients.
Area of Science:
- Immunology
- Microbiology
- Clinical Medicine
Context:
- Leprosy, a chronic infectious disease, requires effective monitoring of treatment efficacy.
- Multibacillary leprosy presents diagnostic and therapeutic challenges.
- Phenolic glycolipid I (PGL-I) is a key antigen in Mycobacterium leprae.
Purpose:
- To evaluate the utility of a solid-phase ELISA using a disaccharide-bovine albumin (DS-BSA) antigen for monitoring leprosy treatment.
- To correlate serological responses with clinical presentation and bacilloscopic findings.
- To assess the effectiveness of chemotherapy in multibacillary leprosy.
Summary:
- Serum samples from 184 leprosy patients were analyzed using ELISA with a semisynthetic PGL-I antigen (DS-BSA).
- Absorbance values >0.160 were considered positive. Multibacillary patients showed a significant decrease in mean absorbance and seropositive ratio with treatment duration.
- Phenolic anti-glycolipid antibodies correlated positively with the bacteriologic index.
Impact:
- This serological method provides a valuable tool for monitoring the effectiveness of chemotherapy in multibacillary leprosy.
- The findings support the use of PGL-I antibody detection for patient management and treatment assessment.
- This approach can aid in optimizing leprosy treatment strategies and improving patient outcomes.
Abstract:
Serum samples from 184 lepers are studied by means of solid phase ELISA with the semisynthetic antigen disaccharide-bovine albumin analogous of phenolic glycolipid I of Mycobacterium leprae. Patients are grouped according to the clinical presentation of the disease and course of time elapsed since the institution of therapy. Bacilloscopic examinations were made also in 116 patients who were positive at diagnosis. For serologic testing, absorbance values over 0,160 were considered positive. Results in multibacillary patients showed a gradual and significant decrease both of mean absorbance values and in the seropositive ratio in connection with the length of treatment. It was also found that phenolic anti glycolipid antibodies increased with the value of the bacteriologic index. This system is useful in monitoring the effectiveness of chemotherapy in multibacillary leprosy.
More Related Videos
06:13Enzyme-linked Immunospot Assay (ELISPOT): Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens
Published on: November 24, 2010
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
